The Clorox Company (clx)
CLX — Company Overview
The Clorox Company (CLX) trades on NYQ as part of the Consumer Defensive peer group (Household & Personal Products).
| Ticker | CLX |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Exchange | NYQ |
| Market cap | $10.15B |
| Last price | $83.94 |
| Size category | Large Cap |
CLX — Business Description
CLX represents a Household & Personal Products business in the Consumer Defensive segment. The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands. It also provides bags and wraps, cat litter, and grilling products under the Glad, Fresh Step, Scoop Away, Kingsford, and Ever Clean brands; and dres…
Official website: https://www.thecloroxcompany.com.
CLX — Investment Thesis
At a high level, CLX offers exposure to Consumer Defensive with metrics outlined below from public market data.
- Revenue is contracting at roughly -2.0% year-over-year (public data).
- Trailing P/E of 16.99× sits in a moderate band relative to high-growth peers.
- Forward P/E (13.41×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 5.7% adds an income component to total return.
- Equity market capitalization is approximately $10.15B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
CLX — Financial Health
Key financial health indicators for The Clorox Company are derived exclusively from public data — no proprietary estimates.
Profit margin near 8.7% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $110.38M supports balance-sheet flexibility. Debt-to-equity of 2221.43 warrants monitoring in a higher-rate environment.
| Trailing P/E | 16.99× |
| Forward P/E | 13.41× |
| Price / Sales | 1.51× |
| Price / Book | 112.82× |
| Gross margin | 42.3% |
| Operating margin | 12.9% |
| Profit margin | 8.7% |
| Return on equity | 1.6% |
| Debt / Equity | 2221.43 |
| Free cash flow | $110.38M |
CLX — Growth Outlook
Growth outlook for The Clorox Company (CLX) depends on demand trends in Household & Personal Products and the company's ability to convert revenue into sustainable earnings.
- Revenue decline of -2.0% highlights near-term demand headwinds.
- Earnings declined -50.1% year-over-year — margin or volume pressure may be in play.
- Price is 34.9% below the 52-week high.
- Shares trade 1.7% above the 52-week low — limited rebound so far.
CLX — Competitive Position
The Clorox Company (CLX) is evaluated against peers on scale, margin structure, and capital efficiency within Consumer Defensive.
- Competes within Consumer Defensive, specifically in Household & Personal Products.
- Market capitalization of $10.15B places CLX among large-cap peers.
- Gross margin near 42.3% may reflect pricing power or favorable mix.
CLX — Strengths
Strengths for The Clorox Company (CLX) inferred from public financial metrics:
- Return on equity near 1.6% — efficient use of shareholder capital.
- Gross margin of 42.3% supports competitive unit economics.
- Positive free cash flow ($110.38M).
- Dividend yield of 5.7% for income-oriented holders.
- Large Cap scale ($10.15B) may provide distribution and funding advantages.
CLX — Weaknesses
Weaknesses and pressure points for The Clorox Company (CLX) based on available data:
- Revenue contraction of -2.0% year-over-year.
- Earnings decline of -50.1% year-over-year.
- Elevated debt-to-equity (2221.43).
- Price 35% below the 52-week high — sustained negative sentiment.
CLX — Opportunities
- Trading 1.7% above the 52-week low — potential recovery if fundamentals stabilize.
- Dividend yield of 5.7% appeals to total-return investors.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
CLX — Risks
- Leverage (debt/equity 2221.43) raises sensitivity to credit conditions.
- Negative revenue growth may signal share loss or cyclical pressure.
CLX — Summary
The Clorox Company (CLX) is a large-cap Consumer Defensive company focused on Household & Personal Products, listed on NYQ. Last price $83.94 with market cap $10.15B. Trailing P/E 16.99×. Revenue declined -2.0% year-over-year per public data. Notable strengths include return on equity near 1.6% — efficient use of shareholder capital. Key watch items include revenue contraction of -2.0% year-over-year. Premium Terminal tools for The Clorox Company add ownership analytics, news, and richer estimate history beyond this public summary.
Start Free — open CLX in Vest Terminal
Access live data, filings, ownership, and analysis for The Clorox Company.
The Clorox Company FAQ
What does The Clorox Company (CLX) do?
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitiz…
What is CLX's P/E ratio?
The Clorox Company has a trailing P/E of 16.99× based on publicly available market data.
Does CLX pay a dividend?
Indicated dividend yield: 5.7%. Confirm ex-dates and payout history in Vest Terminal.
What sector is CLX in?
The Clorox Company is classified in Consumer Defensive (Household & Personal Products) on NYQ.
What is CLX's market capitalization?
Approximate market cap: $10.15B.
What are the main risks for CLX?
Key risks include negative revenue growth, among factors on this page.
What are the strengths of CLX?
Potential positives include return on equity near 1.6% — efficient use of shareholder capital, gross margin of 42.3% supports competitive unit economics.
Where can I get analyst estimates for CLX?
Public analyst price targets and consensus for The Clorox Company are on the free /stocks/clx/estimates page. Deeper estimate history and models are available in Vest Terminal.